Inflammation, aging, and cancer: Tumoricidal versus tumorigenesis of immunity

Cell Biochemistry and Biophysics

Volumn 55, Issue 2, 2009, Pages 55-79

  Khatami, Mahin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aging; Autoimmune and neurodegenerative diseases; Cancer; Hormonal change; Innate and adaptive immunity; Stem cells; Unresolved inflammation

Indexed keywords

AGING; ANIMAL; ARTICLE; CHRONIC DISEASE; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; NEOPLASM;

AGING; ANIMALS; CHRONIC DISEASE; HUMANS; INFLAMMATION; NEOPLASMS;

AVES;

EID: 71449114145     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-009-9059-2     Document Type: Article

References (237)

1. Khatami, M. (2008). "Yin and Yang" in inflammation: Duality in innate immune cell function and tumorigenesis. Expert Opinion on Biological Therapy, 8, 1461-1472.
2. Peggs, K. S., Quezada, S. A., & Allison, J. P. (2008). Cell intrinsic mechanisms of T cell inhibition and application to cancer therapy. Immunological Reviews, 224, 141-165.
3. De La Fuente, M., Hernandez, A., & Vallejo, M. C. (2005). The immune system in the oxidative stress conditions of aging and hypertension: Favorable effects of antioxidants and physical exercise. Antioxidants & Redox Signaling, 7, 1356-1366.
4. Griffin, W. S. (2006). Inflammation and neurodegenerative diseases. American Journal of Clinical Nutrition, 83, 470-474.
5. Bright, J. J., Kanakasabai, S., Chearwae, W., & Chakraborty, S. (2008). PPAR regulation of inflammatory signaling in CNS disease. PPAR Research, 2008, 658520.
6. DiFilippo, C. D., Cuzzocrea, S., Rossi, F., Marfella, R., & D'Amico, M. (2006). Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovascular Drug Review, 24, 77-87.
7. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugate the brain. Nature Reviews Neuroscience, 9, 46-56.
8. Vasto, S., Candore, G., Listi, F., Balistreri, C. R., et al. (2008). Inflammation, genes and zinc in Alzheimer's disease. Brain Research Review, 58, 96-105.
9. von Bernhardi, R. (2007). Glial cell dysregulation: A new perspective on Alzheimer disease. Neurotoxicity Research, 4, 215-232.
10. Walter, S., Letiembre, M., Liu, Y., Heine, H., et al. (2007). Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cellular Physiology and Biochemistry, 20, 947-956.
11. Siffrin, V., Brandt, A. U., Herz, J., & Zipp, F. (2007). New insights into adaptive immunity in chronic neuroinflammation. Advances in Immunology, 96, 1-40.
12. Vaknin-Dembinsky, A., Balashov, K., & Weiner, H. L. (2006). IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. Journal of Immunology, 176, 1768-1774.
13. O'Brien, K., Fitzgerald, D. C., Naiken, K., Alugupalli, K. R., Rostami, A. M., & Gran, B. (2008). Role of the innate immune system in autoimmune inflammatory demyelination. Current Medicinal Chemistry, 15, 1105-1115.
14. Sethi, G., Sung, B., & Aggarwal, B. B. (2008). TNF: A master switch for inflammation and cancer. Frontiers in Bioscience, 13, 5094-5107.
15. Wood, J. D. (2006). Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis and food allergies. Gut, 55, 445-447.
16. Dalgleish, A. G., & O'Bryrne, K. (2006). Inflammation and cancer: The role of immune response and angiogenesis. Cancer Treatment and Research, 130, 1-38.
17. de Visser, K. E., Eichten, A., & Coussens, L. M. (2006). Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer, 6, 24-37.
18. Ignarro, L. J., & Napoli, C. (2005). Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Current Diabetes Reports, 5, 17-23.
19. Aviv, A. (2001). Hypothesis: Pulse pressure and human longevity. Hypertension, 37, 1060-1066.
20. Varo, N., Libby, P., Nuzzo, R., Italiano, J., et al. (2005). Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products. Diabetes & Vascular Disease Research, 2, 81-87.
21. Mundy, G. R. (2007). Osteoporosis and inflammation. Nutrition Reviews, 65, S147-S151.
22. Kay, A. B. (2005). The role of eosinophils in the pathogenesis of asthma. Trends in Molecular Medicine, 11, 148-152.
23. Heins, C., Fanihagh, F., & Steuhl, K. P. (2003). Squamous cell carcinoma of the conjunctiva in patients with atopic eczema. Cornea, 22, 135-137.
24. Karrasch, S., Holz, O., & Jorres, R. A. (2008). Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respiratory Medicine, 102, 1215-1230.
25. Peek, R. M., Jr., & Crabtree, J. E. (2006). Helicobacter infection and gastric neoplasia. Journal of Pathology, 208, 233-248.
26. Bazzichi, L., Rossi, A., Massimetti, G., Giannaccini, G., et al. (2007). Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clinical and Experimental Rheumatology, 25, 225-230.
27. Landau, D. A., Rosenzwaig, M., Saadoun, D., Trebeden-Negre, H., et al. (2008). Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis. Arthritis and Rheumatism, 58, 2897-2907.
28. Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008). Monocyte-mediated defense against microbial pathogens. Annual Review of Immunology, 26, 421-452.
29. Gordon, S., & Taylor, P. R. (2005). Monocyte and macrophage heterogeniety. Nature Reviews Immunology, 5, 953-964.
30. Lodoen, M. B., & Lanier, L. L. (2006). Natural killer cells as an initial defense against pathogens. Current Opinion in Immunology, 18, 391-398.
31. Bonasio, R., & von Andrian, U. H. (2006). Generation, migration and function of circulating dendritic cells. Current Opinion in Immunology, 18, 503-511.
32. Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004). Plasmacytoid dendritic cells in immunity. Nature Immunology, 5, 1219-1226.
33. Gurish, M. F., & Boyce, J. A. (2006). Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell. Journal of Allergy and Clinical Immunology, 117, 1285-1291.
34. Kabelitz, D., & Medzhitov, R. (2007). Innate immunity-cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Current Opinion in Immunology, 19, 1-3.
35. Behrens, M. D., Wagner, W. M., Krco, C. J., Erskine, C. L., et al. (2008). The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity. Blood, 111, 1472-1479.
36. Yi-Deng, J., Tao, S., Hui-Ping, Z., Jian-Tuan, X., et al. (2007). Folate and ApoE DNA methylation induced by homocysteine in human monocytes. DNA and Cell Biology, 26, 737-744.
37. Boldyrev, A. A., & Johnson, P. (2007). Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. Journal of Alzheimer's Disease, 11, 219-228.
38. Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006). Lymphoid organ development: From ontology to neogenesis. Nature Immunology, 7, 344-353.
39. Ferrantini, M., Capone, L., & Belardelli, F. (2008). Dendritic cells and cytokines in immune rejection of cancer. Cytokine and Growth Factor Reviews, 19, 93-107.
40. Khatami, M. (2005). Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium in an experimental model of allergy. Implications for a direct link between inflammation and carcinogenesis. American Journal of Therapeutics, 12, 117-126.
41. Terkeltaub, R., Zachariae, C., Santoro, D., Martin, J., et al. (1991). Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis and Rheumatism, 34, 894-903.
42. Guerra, H. (2007). The brucellae and their success as pathogens. Critical Reviews in Microbiology, 33, 325-331.
43. Matzinger, P. (2002). The danger model: A renewed sense of self. Science, 296, 301-305.
44. Blagosklonny, M. V. (2004). Prospective strategies to enforce selectively cell death in cancer cells. Oncogene, 23, 2967-2975.
45. Kamanna, V. S., & Kashyap, M. L. (2008). Mechanism of action of niacin. American Journal of Cardiology, 17, 20B-26B.
46. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005). Selected toll-like receptor agonist combinations synergically trigger a T helper type 1-polarizing program in dendritic cells. Nature Immunology, 6, 769-776.
47. Sitkovsky, M., Lukashev, D., Deaglio, S., Dwyer, K., et al. (2008). Adenosine A2A receptor antagonists: Blockade of adenosinergic effects and T regulatory cells. British Journal of Pharmacology, 153, S457-S464.
48. Ibaraki, T., Muramatsu, M., Takai, S., et al. (2005). The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage 1 non-small cell cancer. European Journal of Cardio-Thoracic Surgery, 28, 617-621.
49. Katdare, M., Efmova, E. V., Labay, E., Khodarev, N. N., et al. (2007). Diverse TNF-alpha-induced death pathways are enhanced by inhibition of NF-kB. International Journal of Oncology, 31, 1519-1528.
50. Khatami, M. (2007). Standardizing cancer biomarkers criteria: Data elements as a foundation for a database. Inflammatory mediator/M-CSF as model marker. Cell Biochemistry and Biophysics, 47, 187-198.
51. Ridker, P. M. (2007). C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus. Journal of the American College of Cardiology, 49, 2129-2138.
52. Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993). Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. Journal of Biological Chemistry, 268, 26055-26058.
53. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: A double-edged sword. Nature Reviews Immunology, 3, 745-756.
54. Risques, R. A., Rabinovitch, P. S., & Brentnall, T. A. (2006). Cancer surveillance in inflammatory bowel disease: New molecular approaches. Current Opinion in Gastroenterology, 22, 382-390.
55. Royds, J. A., & Iacopetta, B. (2006). P53 and disease: When the guardian angel fails. Cell Death and Differentiation, 13, 1017-1026.
56. Rosales, J. L., & Lee, K.-Y. (2006). Extraneuronal roles of cyclin-dependent kinase 5. BioEssays, 28, 1023-1034.
57. Valent, P., Schernthaner, G. H., Sperr, W. R., Fritsch, G., et al. (2001). Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunological Reviews, 179, 74-81.
58. Jawdat, D. M., Rowden, G., & Marshall, J. S. (2006). Mast cells have pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. Journal of Immunology, 177, 1755-1762.
59. Church, M. K., Holgate, S. T., Shute, J. K., et al. (1998). Mast cell-derived mediators. In E. Middleton Jr., E. F. Ellis, & J. W. Yunginger (Eds.), Allergy: Principles and practice (5th ed., pp. 146-167). Mosby: St. Louis.
60. Kaparakis, M., Walduck, A. K., Price, J. D., Pedersen, J. S., van Rooijen, N., et al. (2008). Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infection and Immunity (Epub ahead of print).
61. Gordon, S. (2003). Alternative activation of macrophages. Nature Reviews Immunology, 3, 23-35.
62. van Ginderachter, J. A., Movahedi, K., Hassanzadeh Ghassabeh, G., Meerschaut, S., et al. (2006). Classical and alternative activation of mononuclear phagocytes: Picking of the best of both worlds for tumor promotion. Immunology, 211, 487-501.
63. Verreck, F. A., de Boer, T., Langenberg, D. M., Hoeve, M. A., et al. (2004). Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria. Proceedings of the National Academy of Science of the United States of America, 101, 4560-4565.
64. Juliet, P. A., Hayashi, T., Iguchi, A., & Ignarro, L. J. (2003). Concomitant production of nitric oxide and superoxide in human macrophages. Biochemical and Biophysical Research Communications, 310, 367-370.
65. Pozzi, L. A., Maciaszek, J. W., & Rock, K. L. (2005). Both dendritic cells and macrophages can stimulate naïve CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. Journal of Immunology, 175, 2071-2081.
66. Dvorak, H. F. (1986). Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine, 315, 1650-1659.
67. Karin, M., & Lin, A. (2002). NF-kappa B at the crossroads of life and death. Nature Immunology, 3, 221-227.
68. Akdis, M. (2008). T cell tolerance to inhaled allergens: Mechanisms and therapeutic approaches. Expert Opinion on Biological Therapy, 8, 769-777.
69. Quezada, S. A., Jarvinen, L. Z., Lind, E. F., & Noelle, R. J. (2004). CD40/CD154 interactions at the interface of tolerance and immunity. Annual Review of Immunology, 22, 307-328.
70. Khatami, M. (1999). Induction of conjunctival-associated lymphoid hyperplasia by antigen and tumor promoting agents: Targeting mediators of inflammatory responses as biomarkers for early detection of tumor/cancer. In AACR special conference proceedings: The biology and genetics of early detection and chemoprevention of cancer (Abstr), Bal Harbour, FL.
71. Mroczko, B., Groblewska, M., Wereszczynska-Siemiatkowska, U., Okulczyk, B., et al. (2007). Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clinica Chimica Acta, 380, 208-212.
72. Kucharewicz, I., Bodzenta-Lukaszyk, A., Szymanski, W., Mroczko, B., & Szmitkowski, M. (2007). Basal serum tryptase level correlates with severity of hymenoptera sting and age. Journal of Investigational Allergology and Clinical Immunology, 17, 65-69.
73. Suzuki, M., Kobayashi, H., Ohwada, M., Terao, T., et al. (1998). Macrophage-colony stimulating factor as a marker for malignant germ cell tumors of the ovary. Gynecologic Oncology, 68, 35-37.
74. Wagner, D. D., & Frenette, P. S. (2008). The vessel wall and its interactions. Blood, 111, 5271-5281.
75. Huttenlocher, A., & Poznansky, M. C. (2008). Reverse leukocyte migration can be attractive or repulsive. Trends in Cell Biology, 18, 298-306.
76. Bellone, M., Mondino, A., & Corti, A. (2008). Vascular targeting, chemotherapy and active immunotherapy: Teaming up to attack cancer. Trends in Immunology, 29, 235-241.
77. Nurden, A. T., Nurden, P., Sanchez, M., Andia, I., & Anitua, E. (2008). Platelets and wound healing. Frontiers in Bioscience, 13, 3532-3548.
78. Jackson, S. P. (2007). The growing complexity of platelet aggregation. Blood, 109, 5087-5095.
79. Anitua, E., Andia, I., Ardanza, B., Nurden, P., & Nurden, A. T. (2004). Autologous platelets as a source of proteins for healing and tissue regeneration. Thrombosis and Haemostasis, 91, 4-15.
80. Stenmark, K. R., Fagan, K. A., & Frid, M. G. (2006). Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circulation Research, 99, 675-691.
81. Peerschke, E. I., Yin, W., Grigg, S. E., & Ghebrehiwet, B. (2006). Blood platelets activate the classical pathways of human complement. Journal of Thrombosis and Haemostasis, 4, 2035-2042.
82. Madonna, R., Massaro, M., & De Caterina, R. (2008). Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells. Biochimica et Biophysica Acta, 1782, 511-516.
83. Tobin, M. J. (2001). Chronic obstructive disease, pollution, pulmonary vascular disease, transplantation, pleural disease and lung cancer. American Journal of Respiratory and Critical Care Medicine, 164, 1789-1804.
84. Li, W., Khatami, M., Robertson, G. A., Shen, S., & Rockey, J. H. (1984). Non-enzymatic glycosylation of bovine retinal microvessel basement membrane in vitro: Kinetic analysis and inhibition by aspirin. Investigative Ophthalmology & Visual Science, 25, 884-892.
85. Khatami, M. (2006). Focusing on promotion of innate immune response system for therapy, diagnosis and prevention of tumor/cancer (abstract). In 4th annual cytokine and inflammation conference (pp. 30-31). San Diego, CA.
86. Niederkorn, J. Y. (2006). See no evil, hear no evil, do no evil: The lessons of immune privilege. Nature Immunology, 7, 354-359.
87. Zamiri, P., Sugita, S., & Streilein, J. W. (2007). Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chemical Immunology and Allergy, 92, 86-93.
88. Naito, M., & Itoh, M. (2008). Patterns of infiltration of lymphocytes into the testis under normal and pathological conditions in mice. American Journal of Reproductive Immunology, 59, 55-61.
89. Hamrah, P., Huq, S. O., Liu, Y., Zhang, Q., & Dana, M. R. (2003). Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. Journal of Leukocyte Biology, 74, 172-178.
90. Streilein, J. W., Masli, S., Takeuchi, M., & Kezuka, T. (2002). The eye's view of antigen presentation. Human Immunology, 63, 435-443.
91. Fischer, H. G., & Reichmann, G. (2001). Brain dendritic cells and macrophages/microglia in central nervous system inflammation. Journal of Immunology, 166, 2717-2726.
92. Yamamoto, E., Tamamaki, N., Nakamura, T., Kataoka, K., et al. (2008). Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke, 39, 3046-3056.
93. Gran, B., Zhang, G. X., & Rostami, A. (2004). Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Critical Reviews in Immunology, 24, 111-128.
94. Owens, T., & Babcock, A. (2002). Immune response induction in the central nervous system. Frontiers in Bioscience, 7, d427-d438.
95. Karman, J., Linq, C., Sandor, M., & Fabry, Z. (2004). Initiation of immune responses in brain is promoted by local dendritic cells. Journal of Immunology, 173, 2353-2361.
96. Scholz, M., Doerr, H. W., & Cinatl, J. (2003). Human cytomegalovirus retinitis: Pathogenicity, immune evasion and persistence. Trends in Microbiology, 11, 171-178.
97. Knoernschild, T., Grasbon, T., Wilsch, C., Kampik, A., & Lutjen-Drecoll, E. (2003). RPE cell transplants to non-immune-privileged sites of the eye transform into fibroblast-like cells. Current Eye Research, 27, 25-34.
98. Dheen, S. T., Kaur, C., & Ling, E. A. (2007). Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry, 14, 1189-1197.
99. Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconelos, J., et al. (2007). GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the autoimmune encephalomyelitis. Journal of Immunology, 178, 39-48.
100. Zaheer, A., Zaheer, S., Sahu, S. K., Knight, S., Khosravi, H., et al. (2007). A novel role of glia maturation factor: Induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. Journal of Neurochemistry, 101, 364-376.
101. Volmar, C. H., Ait-Ghezala, G., Frieling, J., Paris, D., & Mullan, M. J. (2008). The granulocyte macrophage colony stimulating factor (GM-CSF) regulates amyloid beta (Abeta) production. Cytokine, 42, 336-344.
102. Widera, D., Kaus, A., Kaltschmidt, C., & Kaltschmidt, B. (2008). Neuronal stem cells, inflammation and NF-kB: Basic principle of maintenance and repair or origin of brain tumours? Journal of Cellular and Molecular Medicine, 12, 459-470.
103. Goronzy, J. J., & Weyand, C. M. (2005). T cell development and receptor diversity during aging. Current Opinion in Immunology, 17, 468-475.
104. Capri, M., Monti, D., Salvioli, S., Lescai, F., et al. (2006). Complexity of anti-immunoscenescence strategies in humans. Artificial Organs, 30, 730-742.
105. Xiao, S., Jin, H., Korn, T., Liu, S. M., et al. (2008). Retinoic acid increases Foxp3+ regulatory T cell and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. Journal of Immunology, 181, 2277-2284.
106. Jessup, H. K., Brewer, A. W., Omori, M., Rickel, E. A., et al. (2008). Intradermal administration of thymic stromal lymphopoietin induces a T cell-and eosinophil-dependent systemic th2 inflammatory response. Journal of Immunology, 181, 4311-4319.
107. Harvey, B. P., Quan, T. E., Rudenga, B. J., Roman, R. M., et al. (2008). Editing antigen presentation: Antigen transfer between human lymphocytes and macrophages mediated by class A scavenger receptors. Journal of Immunology, 181, 4043-4051.
108. Kohlmeier, J. E., Miller, S. C., Smith, J., Lu, B., et al. (2008). The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity, 29, 101-113.
109. Doganci, A., Karwot, R., Maxeiner, J. H., Scholtes, P., et al. (2008). IL-2 receptor beta-chain signaling controls immunosuppressive CD4+ T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo. Journal of Immunology, 181, 1917-1926.
110. Peggs, K. S., & Allison, J. P. (2005). Co-stimulatory pathways in lymphocyte regulation: The immunoglobulin superfamily. British Journal of Haematology, 130, 809-824.
111. Anderson, C. F., Gerber, J. S., & Mosser, D. M. (2002). Modulating macrophage function with IgG immune complexes. Journal of Endotoxin Research, 8, 477-481.
112. Diz, R., McCray, S. K., & Clarke, S. H. (2008). B cell receptor affinity and B cell subset identity integrate to define the effectiveness, affinity threshold, and mechanism of anergy. Journal of Immunology, 181, 3834-3840.
113. Donshik, P. C., Ehlers, W. H., & Ballow, M. (2008). Giant papillary conjunctivitis. Immunology and Allergy Clinics of North America, 28, 83-103.
114. Khatami, M. (2005). Cyclooxygenase inhibitor Ketorolac or mast cell stabilizers: Immunological challenges in cancer therapy. Clinical Cancer Research, 11, 1349-1351.
115. Rafi, A., Castle, S. C., Uvemura, K., & Makinodan, T. (2003). Immune dysfunction in the elderly and its reversal by antihistamines. Biomedicine and Pharmacotherapy, 57, 246-250.
116. Jones, M. (2008). Understanding of the molecular mechanisms of allergy. Methods in Molecular Medicine, 138, 1-15.
117. Anthony, R. M., Rutitzky, L. I., Urban, J. F., Jr., Stadecker, M. J., et al. (2007). Protective immune mechanisms in helminth infection. Nature Reviews. Immunology, 7, 975-987.
118. Audicana, M. T., & Kennedy, M. W. (2008). Anisakis simplex: From obscure infectious worm to inducer of immune hypersensitivity. Clinical Microbiology Reviews, 21, 360-379.
119. Harvima, I. T., Nilsson, G., Suttle, M.-M., & Naukkarinen, A. (2008). Is there a role for mast cells in psoriasis. Archives of Dermatological Research, 300, 461-478.
120. Dvorak, A. M., Costa, J. J., Monahan-Early, R. A., Fox, P., & Galli, S. J. (1998). Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: Subcutaneous injection of rhSCF induces mast cell degranulation and granulation and granulocyte recruitment at the injection site. Journal of Allergy and Clinical Immunology, 101, 793-806.
121. Metz, M., Magerl, M., Kuhl, N. F., Valeva, A., et al. (2009). Mast cells determine the magnitude of bacterial toxin-induced skin inflammation. Experimental Dermatology, 18, 160-166.
122. Wimazal, F., Baumgartner, C., Sonneck, K., Zauner, C., et al. (2008). Mixed-lineage eosinophil/basophil crisis in MDS: A rare form of progression. European Journal of Clinical Investigation, 38, 447-455.
123. DiScipio, R. G., & Schraufstatter, I. U. (2007). The role of the complement anaphylatoxins in the recruitment of eosinophils. International Immunopharmacology, 7, 1909-1923.
124. Kohga, K., Takehara, T., Tatsumi, T., Ohkawa, K., et al. (2008). Serum levels of soluble major histocompatibility complex (MHC) classI-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Science, 99, 1643-1649.
125. Junushi, M., Vanneman, M., Munshi, N. C., Tai, Y. F., et al. (2008). MHC class I chain-related protein antibodies and shedding are associated with the progression of multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America, 105, 1285-1290.
126. Sansoni, P., Vescovoni, R., Fagnoni, F., Biasini, C., Zanni, F., et al. (2008). The immune system in extreme longevity. Experimental Gerontology, 43, 61-65.
127. Kreider, T., Anthony, R. M., Urban, J. F., Jr., & Gause, W. C. (2007). Alternatively activated macrophages in helminth infections. Current Opinion in Immunology, 19, 448-453.
128. Murdoch, C., & Lewis, C. E. (2005). Macrophage migration and gene expression in response to tumor hypoxia. International Journal of Cancer, 117, 701-708.
129. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., et al. (2006). A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kB and enhanced IRF-3/STAT1 activation). Blood, 107, 2112-2122.
130. Krampera, M., Sartoris, S., Liotta, F., Pasini, A., et al. (2007). Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells and Development, 16, 797-810.
131. Ballard, V. L., & Edelberg, J. M. (2007). Stem cells and the regeneration of the aging cardiovascular system. Circulation Research, 100, 1116-1127.
132. Bhandoola, A., von Boehmer, H., Petrie, H. T., & Zuniga-Pflucker, J. C. (2007). Commitment and development potential of extrathymic and intrathymic T cell precursors: Plenty to choose from. Immunity, 26, 678-689.
133. Yunis, E. J., Zuniga, J., Koda, P. S., Husain, Z., Romero, V., et al. (2006). Stem cells in aging: Influence of ontogenic, genetic and environmental factors. Journal of Stem Cells, 1, 125-147.
134. Fendrick, A. M., & Baldwin, J. L. (2001). Allergen-induced inflammation and the role of immunoglobulin E (IgE). American Journal of Therapeutics, 8, 291-297.
135. Emre, Y., Hurtaud, C., Karaca, M., Nubel, T., et al. (2007). Role of uncoupling protein UCP2 in cell-mediated immunity: How macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes. Proceedings of the National Academy of Science of the United States of America, 104, 19085-19090.
136. al-Sarireh, B., & Eremin, O. (2000). Tumour-associated macrophages (TAMs): Disordered function, immune suppression and progressive tumour growth. Journal of the Royal College of Surgeons of Edinburg, 45, 1-16.
137. Kusmartsev, S., & Gabrilovich, D. I. (2005). STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. Journal of Immunology, 174, 4880-4891.
138. Mantovani, A., Locati, M., Vecchi, A., Sozzani, S., & Allavena, P. (2001). Decoy receptors: A strategy to regulate inflammatory cytokines and chemokines. Trends in Immunology, 22, 328-336.
139. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., et al. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology, 25, 677-686.
140. Noel, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P., et al. (2004). Alternatively activated macrophages during parasite infections. Trends in Parasitology, 20, 126-133.
141. Willment, J. A., Lin, H. H., Reid, D. M., Taylor, P. R., et al. (2003). Dectin-1 expression and function are enhanced on alternatively activated GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. Journal of Immunology, 171, 4569-4573.
142. Nardin, A., & Abastado, J. P. (2008). Macrophages and cancer. Frontiers in Bioscience, 13, 3494-3505.
143. Massi, D., Marconi, C., Franchi, A., Bianchini, F., et al. (2007). Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: Evidence from human and experimental tumors. Human Pathology, 38, 1516-1525.
144. Ochoa, A. C., Zea, A. H., Hernandez, C., & Rodriguez, P. C. (2007). Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clinical Cancer Research, 13, 721s-726s.
145. Accioly, M. T., Pacheco, P., Maya-Monteiro, C. M., Carrossini, N., et al. (2008). Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Research, 68, 1732-1740.
146. Cahlin, C., Lonnroth, C., Arvidsson, A., Nordgren, S., & Lundholm, K. (2008). Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content. International Journal of Oncology, 32, 909-918.
147. Liang, X., Wu, L., Wang, Q., Hand, T., et al. (2007). Function of COX-2 and prostaglandins in neurological diseases. Journal of Molecular Neuroscience, 33, 94-99.
148. Zisman, T. L., & Rubin, D. T. (2008). Colorectal cancer and dysplasia in inflammatory bowel disease. World Journal of Gastroenterology, 14, 2662-2669.
149. Isik, A., Koca, S. S., Ustundag, B., & Selek, S. (2007). Decreased total antioxidant response and increased oxidative stress in Behcet's disease. Tohoku Journal of Experimental Medicine, 212, 133-141.
150. Mytar, B., Siedlar, M., Woloszyn, M., Ruggiero, L., et al. (1999). Induction of reactive oxygen intermediates in human monocytes by tumor cells and their role in spontaneous cytotoxicity. British Journal of Cancer, 79, 737-743.
151. Busi, J. V., Mohr, S., & Grant, M. B. (2008). Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes, 57, 1952-1965.
152. Johnson, F., & Giulivi, C. (2005). Superoxide dismutases and their impact upon human health. Molecular Aspects of Medicine, 26, 340-352.
153. Ugur, M., Yildirim, K., Kiziltunc, A., Erdal, A., Karatay, S., & Senel, K. (2004). Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: A possible association with disease activity. Scandinavian Journal of Rheumatology, 33, 239-243.
154. Afonso, V., Champy, R., Mitrovic, D., Collin, P., & Lomri, A. (2007). Reactive oxygen species and superoxide dismutases: Role in joint diseases. Joint Bone Spine, 74, 324-329.
155. Haddad, J. J. (2002). Antioxidant and prooxidant mechanisms in the regulation of redox (y)-sensitive transcription factors. Cell Signal, 14, 879-897.
156. Valko, M., Morris, H., & Cronin, M. T. (2005). Metals, toxicity and oxidative stress. Current Medicinal Chemistry, 12, 1161-1208.
157. Ginaldi, L., Martinis, M. D., Monti, D., & Franceschi, C. (2005). Chronic antigenic load and apoptosis in immunosenescence. Trends in Immunology, 28, 79-84.
158. Muller, A. J., Sharma, M. D., Chandler, P. R., Duhadaway, J. B., Everhart, M. E., et al. (2008). Chronic inflammation that facilitate tumor progression create local immune suppression by inducing indoleamine 2, 3 dioxygenase. Proceedings of the National Academy of Sciences of the United States of America, 105, 17073-17078.
159. Katoh, M., & Katoh, M. (2007). STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review). International Journal of Molecular Medicine, 19, 273-278.
160. Zhu, X., Gui, J., Dohkan, J., Cheng, L., et al. (2007). Lymphohematopoietic progenitors do not have a synchronized defect with age-related thymic involution. Aging Cell, 6, 663-672.
161. Candore, G., Balistreri, C. R., Colonna-Romano, G., Grimaldi, M. P., et al. (2008). Immunosenescence and anti-immunusenescence therapies: The case of probiotics. Rejuvenation Research, 11, 425-432.
162. Taupin, P. (2008). Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells. International Journal of Medicinal Science, 5, 127-132.
163. Wada, H., Masuda, K., Satoh, R., Kakugawa, K., et al. (2008). Adult T-cell progenitors retain myeloid potential. Nature, 452, 768-772.
164. Huttunen, M., Naukkarinen, A., Horsmanheimo, M., & Harvima, I. T. (2002). Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing. Archives of Dermatological Research, 294, 324-330.
165. Nikolich-Zugich, J. (2008). Ageing and life-long maintenance of T-cell subsets in the face of latent persistence infections. Nature Reviews Immunology, 8, 512-522.
166. Kuilman, T., Michaloglou, C., Vredeveld, L. C., Douma, S., et al. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell, 133, 1019-1031.
167. Snanoudi, R., Beaudreuil, S., Arzouk, N., de Preneuf, H., et al. (2005). Immunological strategies targeting B cells in organ grafting. Transplantation, 79, S33-S36.
168. Yung, R. L., & Julius, A. (2008). Epigenetics, aging, and autoimmunity. Autoimmunity, 41, 329-335.
169. Shames, D. S., Minna, J. D., & Gazdar, A. F. (2007). DNA methylation in health, disease, and cancer. Current Molecular Medicine, 7, 85-102.
170. Martin, G. M. (2007). The genetics and epigenetics of altered proliferative homeostasis in ageing and cancer. Mechanisms of Ageing and Development, 128, 9-12.
171. Duff, G. W. (2007). Influence of genetics on disease susceptibility and progression. Nutrition Reviews, 65, S177-S181.
172. Ushijima, T., & Okochi-Takada, E. (2005). Aberrant methylation in cancer cells: Where do they come from. Cancer Science, 96, 206-211.
173. Sedivy, J. M., Banumathy, G., & Adams, P. D. (2008). Aging by epigenetics-A consequence of chromatin damage? Experimental Cell Research, 314, 1909-1917.
174. Maekawa, M., & Watanabe, Y. (2007). Epigenetics: Relations to disease and laboratory findings. Current Medicinal Chemistry, 14, 2642-2653.
175. Deng, Y., Chan, S. S., & Chang, S. (2008). Telomere dysfunction and tumour suppression: The senescence connection. Nature Reviews Cancer, 8, 450-458.
176. Aubert, G., & Lansdorp, P. M. (2008). Telomeres and aging. Physiological Reviews, 88, 557-579.
177. Azzalin, C. M., & Lingner, J. (2008). Telomeres: The silence is broken. Cell Cycle, 7, 1161-1165.
178. Ju, Z., & Rudolph, K. L. (2006). Telomeres and telomerase in stem cells during aging and disease. Genome Dynamics, 1, 84-103.
179. Cong, Y., & Shay, J. W. (2008). Actions of human telomerase beyond telomeres. Cell Research, 18, 725-732.
180. Han, J., & Sun, P. (2007). The pathways to tumor suppression via route p38. Trends in Biochemical Sciences, 32, 364-371.
181. Song, Z., Ju, Z., & Rudolph, K. L. (2009). Cell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status. Experimental Gerontology, 44, 75-82.
182. Osborne, C., Wilson, P., & Tripathy, D. (2004). Oncogenes and tumor suppressor genes in breast cancer: Potential diagnostic and therapeutic applications. Oncologist, 9, 361-377.
183. Hince, M., Sakkal, S., Vlahos, K., Dudakov, J., et al. (2008). The role of sex steroids and gonadectomy in the control of thymic involution. Cellular Immunology, 252, 122-138.
184. Leowattana, W. (2001). DHEA(S): The fountain of youth. Journal of Medicinal Association of Thailand, 84(2), 5605-5612.
185. Bosland, M. C. (2006). Sex steroids and prostate carcinogenesis: Integrated, multifactorial working hypothesis. Annals of the New York Academy of Sciences, 1089, 168-176.
186. Risbridger, G. P., Ellem, S. J., & McPherson, S. J. (2007). Estrogen action on the prostate gland: A critical mix of endocrine and paracrine signaling. Journal of Molecular Endocrinology, 39, 183-188.
187. Mikkola, T. S., & Clarkson, T. B. (2002). Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovascular Research, 53, 605-619.
188. Schwartz, A. G., & Pashko, L. L. (2004). Dehydroepiandosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Research Review, 3, 171-187.
189. Schumacher, M., Guennoun, R., Stein, D. G., & De Nicola, A. F. (2007). Progestrone: Therapeutic opportunities for neuroprotection and myelin repair. Pharmacology & Therapeutics, 116, 77-106.
190. Godsland, I. F., & Johnston, D. G. (2008). Co-association between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology. Metabolism, 57, 1190-1197.
191. Harvima, I. T., Lappalainen, K., Hirvonen, M.-R., Matto, M., et al. (2004). Heparin modulate the growth and adherence and augments the growth-inhibitory action of TNF-a on cultured human keratinocytes. Journal of Cellular Biochemistry, 92, 372-386.
192. Oto, J., Suzue, A., Inui, D., Fukuta, Y., et al. (2008). Plasma proinflammatory and anti-inflammatory cytokine and catecholamines as predictors of neurological outcome in acute stroke patients. Journal of Anesthesia, 22, 207-212.
193. Bajenoff, M., Glaichenhaus, N., & Germain, R. N. (2008). Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. Journal of Immunology, 181, 3947-3954.
194. Fischetti, F., & Tedesco, F. (2006). Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. Autoimmunity, 39, 417-428.
195. Li, W., Shen, S., Khatami, M., & Rockey, J. H. (1984). Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high glucose concentration. Diabetes, 33, 785-789.
196. Khatami, M. (1988). Na+-Linked active transport of ascorbate into cultured bovine retinal pigment epithelial cells: Heterologous inhibition by glucose. Membrane Biochemistry, 7, 115-130.
197. Li, W., Shen, S., Robertson, G., Khatami, M., & Rockey, J. H. (1984). Increased solubility of newly synthesized collagen in retinal capillary pericyte cultures by nonenzymatic glycosylation. Ophthalmic Research, 16, 315-321.
198. Li, W., Chan, L. S., Khatami, M., & Rockey, J. H. (1986). Non-competitive inhibition of myo-inositol transport in cultured bovine retinal capillary pericytes by glucose and reversal by sorbinil. Biochimica et Biophysica Acta, 857, 198-208.
199. Khatami, M., & Rockey, J. H. (1988). Regulation of uptake of inositol by glucose in cultured retinal pigment epithelial cells. Biochemistry and Cell Biology, 66, 951-957.
200. Helleboid, L., Khatami, M., Wei, Z.-G., & Rockey, J. H. (1991). Histamine and prostacyclin: Primary and secondary release in allergic conjunctivitis. Investigative Ophthalmology and Visual Science, 32, 2281-2289.
201. Poulsen, R. C., & Kruger, M. C. (2006). Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukotrienes and Essential Fatty Acids, 75, 419-427.
202. Duque, G. (2008). Bone and fat connection in aging bone. Current Opinion in Rheumatology, 20, 429-434.
203. Plourde, M., Jew, S., Cunnane, S. C., & Jones, P. J. (2008). Conjugated linoleic acids: Why the discrepancy between animal and human studies? Nutrition Reviews, 66, 415-421.
204. Basu, S. (2008). F2-isoprostanes in human health and diseases: From molecular mechanisms to clinical implications. Antioxidants Redox Signaling, 10, 1405-1434.
205. Tuder, R. M., Yun, J. H., & Graham, B. B. (2008). Cigarette smoke triggers code red: p21CIP1/WAF1/SDI1 switches on danger responses in the lung. American Journal of Respiratory Cell and Molecular Biology, 39, 1-6.
206. Zell, J. A., Ignatenko, N. A., Yerushalmi, H. F., Ziogas, A., et al. (2007). Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. International Journal of Cancer, 120, 459-468.
207. Popovic, P. J., Zeh, H. J., 3rd, & Ochoa, J. B. (2007). Arginine and immunity. Journal of Nutrition, 137, 1681S-1686S.
208. Tate, D. J. Jr., Vonderhaar, D. J., Caldas, Y. A., Metover, T., et al. (2008). Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma. Journal of Hematology and Oncology, 1, 1-14.
209. Tsilidids, K. K., Branchini, C., Guallar, E., Helzlsouer, K. J., et al. (2008). C-reactive protein and colorectal cancer risk: A systematic review of prospective studies. International Journal of Cancer, 123, 1133-1140.
210. Takanami, I., Takeuchi, K., & Naruke, M. (2000). Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer, 88, 2686-2692.
211. Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008). Immunological aspects of cancer chemotherapy. Nature Reviews Immunology, 8, 59-73.
212. Swann, J. B., Vesely, M. D., Silva, A., Sharkey, J., et al. (2008). Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 105, 652-658.
213. Peggs, K. S., Quezada, S. A., Korman, A. J., & Allison, J. P. (2006). Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Current Opinion in Immunology, 18, 206-213.
214. Karran, P., & Attard, N. (2008). Thiopurine in current medical practice: Molecular mechanisms and contributions to therapy-related cancer. Nature Reviews Cancer, 8, 24-36.
215. Boon, T., Coulie, P. G., van den Eynde, B. J., & van der Bruggen, P. (2006). Human T cell responses against melanoma. Annual Review of Immunology, 24, 175-208.
216. Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001). A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunology, 2, 293-299.
217. Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008). Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Accounts of Chemical Research, 41, 120-129.
218. Peggs, K. S. (2006). Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans. Cytotherapy, 8, 427-436.
219. Ehrlich, P. (1909). Uber den jetzigen Stand der Karzinomforschung. Nederlands Tijdschrift voor Geneeskunde, 5, 273-290.
220. Burnet, M. (1957). Cancer; a biologic approach. I. The processes of control. British Medical Journal, 1, 779-786.
221. Thomas, L. (1959). Reactions to homologous tissue antigens in relation to hypersensitivity. In H. S. Lawrence (Ed.), Cellular and humoral aspects of the hypersensitive states (pp. 529-532). New York: Hoeber-Harper.
222. Burnet, F. M. (1971). Immunological surveillance in neoplasia. Transplantation Reviews, 7, 3-25.
223. Stanely, M. A., Pett, M. R., & Coleman, N. (2007). HPV: From infection to cancer. Biochemical Society Transactions, 35, 1456-1460.
224. Eissa, S., Ahmed, M. I., Said, H., Zaghlool, A., & El-Ahmady, O. (2004). Cell cycle regulation in bladder cancer: Relationship to schistosomiasis. IUBMB Life, 56, 557-564.
225. Khatami, M., Donnelly, J. J., Haldar, J. P., & Rockey, J. H. (1989). Massive follicular lymphoid hyperplasia in experimental chronic recurrent allergic conjunctivitis. Archives of Ophthalmology, 107, 433-438.
226. Khatami, M., Donnelly, J. J., John, T., & Rockey, J. H. (1984). Vernal conjunctivitis Model studies in guinea pigs immunized topically with fluoresceinyl ovalbumin. Archives of Ophthalmology, 102, 1683-1688.
227. Khatami, M., Donnelly, J. J., & Rockey, J. H. (1985). Induction and down-regulation of conjunctival type-1 hypersensitivity reactions in guinea pigs sensitized topically with fluoresceinyl ovalbumin. Ophthalmic Research, 17, 139-147.
228. Suldan, Z., Khatami, M., Wei, Z.-G., Donnelly, J. J., et al. (1988). Induction of conjunctival lymphoid hyperplasia by phorbol ester and antigen. FASEB Abstracts, 2, 51.
229. Haldar, J. P., Khatami, M., Donnelly, J. J., & Rockey, J. H. (1988). Experimental allergic conjunctivitis. Production of different isotypes of antibody by conjunctival-associated lymphoid tissue in culture. Regional Immunology, 1, 92-99.
230. Rockey, J. H., Donnelly, J. J., John, T., Khatami, M., et al. (1985). IgE antibodies in ocular immunopathology. In G. R. O' Conner, & J. W. Chandler (Eds.), Advances in immunology and immunopathology of the eye (pp. 199-202). Masson Publishing.
231. Haldar, J. P., Khatami, M., Lok, J. B., Rockey, J. H., & Donnelly, J. J. (1990). Experimental ocular onchocerciasis. Local and systemic antibody and cell mediated immune response. Tropical Medicine and Parasitology, 41, 234-240.
232. Helleboid, L., Khatami, M., & Rockey, J. H. (1991). Thromboxane and neurotransmitters in Type 1 conjunctival reactions. Investigative Ophthalmology and Visual Science, 32(SUPPL), 679.
233. Donnelly, J. J., Sakla, A. A., Hill, D. E., Lok, J. B., et al. (1987). Effect of diethylcarbamazine citrate and anti-inflammatory drugs on experimental onchocercal punctate keratitis. Ophthalmic Research, 19, 129-134.
234. Hansen, A., Gosemann, M., Pruss, A., et al. (2004). Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis and Rheumatism, 50, 1897-1908.
235. Leiper, K., Campbell, B. J., Jenkinson, M. D., Milton, J., et al. (2001). Interaction between bacterial peptides, neutrophils and goblet cells: A possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. Clinical Science (London), 101, 395-402.
236. Henson, D. E., & Alborez-Saavedra, J. (Eds.). (2001). In Pathology of incipient neoplasia, 3rd edition. Oxford: Oxford University Press.
237. Khatami, M. (1999). Mediators of chronic inflammation as risk/susceptibility factors for early detection of cancer in an adult population. NCI/NIH documents.